Special Issue "High Mobility Group Box-1 (HMGB1) in a Neuroimmune Crosstalk"
Deadline for manuscript submissions: 30 November 2023 | Viewed by 4670
Interests: high-mobility group box 1 (HMGB1); T-type calcium channel; hydrogen sulfide; proteinase-activated receptor (PAR); neuroinflammation; pain
Special Issues, Collections and Topics in MDPI journals
Special Issue in Cells: Cell Biology: State-of-the-Art and Perspectives in Japan
High-mobility group box 1 (HMGB1), a nuclear protein, is passively released from dying cells, actively secreted by certain cells, and functions as a damage-associated molecular pattern protein. Extracellular HMGB1 directly or indirectly activates some pattern recognition receptors (PRRs), such as Toll-like receptors (TLR) 2 and 5, the receptor for advanced glycation end product (RAGE), CXC chemokine receptor 4 (CXCR4), etc., and plays multiple roles in health and disease. Given the release of HMGB1 from immune cells, including macrophages and also neurons that express HMGB1-targeted PRRs, HMGB1 is considered a mediator in the communication between immune cells and neurons. Such a neuroimmune crosstalk is essential for neuroinflammation, and is involved in the inception and/or progression of various CNS and PNS diseases, such as stroke, neurodegenerative and psychiatric disorders, and neuropathic pain. Therefore, this Special Issue focuses on the role of HMGB1 in neuroimmune interactions.
Prof. Dr. Atsufumi Kawabata
Prof. Dr. Masahiro Nishibori
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- damage-associated molecular patterns (DAMPs)
- pattern recognition receptors (PRRs)
- neurogenic inflammation